Canada Pension Plan Investment Board’s Maze Therapeutics MAZE Stock Holding History

Canada Pension Plan Investment Board’s Portfolio MAZE Stock Details MAZE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$272K	Buy	+9,100	New	+$239K	﹤0.01%	1495

Other funds holding MAZE

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

TGI

TRV GP IV Boston, Massachusetts $254M AUM 426.76% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACM

AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return

Canada Pension Plan Investment Board's MAZE Position: Q2 2026 in Review

Canada Pension Plan Investment Board opened a new position in Maze Therapeutics (MAZE) in Q2 2026: 9,100 shares worth $272K. The stake represents ﹤0.01% of the portfolio and ranks #1495 among its holdings.

162 funds tracked by Wall St. Rank hold MAZE as of Q2 2026.

Canada Pension Plan Investment Board held 9,100 shares of Maze Therapeutics worth $272K as of Q2 2026.
Maze Therapeutics was a new Canada Pension Plan Investment Board position in Q2 2026.
Maze Therapeutics made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #1495 holding.
162 funds tracked by Wall St. Rank held Maze Therapeutics as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.